ReviewCell death discovery2026
Reprogramming temozolomide response in glioblastoma through regulated and immunogenic cell death modalities.
Tatiana A Mishchenko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it